SOPHiA GENETICS (SOPH) Payables (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Payables data on file, last reported at $9.0 million in Q4 2025.

• For the quarter ending Q4 2025, Payables rose 71.65% year-over-year to $9.0 million; the trailing twelve-month figure through Dec 2025 stood at $9.0 million (up 71.65% YoY), and the FY2025 full-year result was $9.0 million, up 71.65% from the prior year.
• Payables advanced to $9.0 million in Q4 2025, from $6.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $9.0 million in Q4 2025 to a low of $4.6 million in Q1 2025.
• A 5-year average of $6.5 million and a median of $6.2 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables sank 35.93% in 2022 and soared 71.65% in 2025, its largest moves.
• Tracing SOPH's Payables over 5 years: stood at $6.7 million in 2021, then fell by 8.25% to $6.2 million in 2022, then fell by 12.78% to $5.4 million in 2023, then declined by 3.17% to $5.2 million in 2024, then soared by 71.65% to $9.0 million in 2025.
• Business Quant data shows SOPH's Payables at $9.0 million in Q4 2025, $6.1 million in Q3 2025, and $7.7 million in Q2 2025.